Global CRISPR And CRISPR-Associated (Cas) Genes Market Growth 2020-2025


Apr, 2020 | Report ID: 138242 | 164 | Pharmaceuticals and Healthcare

COVID-19, the disease it causes, surfaced in late 2019, and now had become a full-blown crisis worldwide. Over fifty key countries had declared a national emergency to combat coronavirus. With cases spreading, and the epicentre of the outbreak shifting to Europe, North America, India and Latin America, life in these regions has been upended the way it had been in Asia earlier in the developing crisis. As the coronavirus pandemic has worsened, the entertainment industry has been upended along with most every other facet of life. As experts work toward a better understanding, the world shudders in fear of the unknown, a worry that has rocked global financial markets, leading to daily volatility in the U.S. stock markets.

According to this latest study, the 2020 growth of CRISPR And CRISPR-Associated (Cas) Genes will have significant change from previous year. By the most conservative estimates of global CRISPR And CRISPR-Associated (Cas) Genes market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ 698.3 million in 2019. We give this scenario a XX% probability, where under the scenario the supply chain will start to recover and quarantines and travel bans will ease, over the Q2. Longer-term, the effect of COVID-19 will be felt throughout the year with some degree of harm done by the virus. Over the next five years the CRISPR And CRISPR-Associated (Cas) Genes market will register a XX% CAGR in terms of revenue, the global market size will reach US$ XX million by 2025.

This report presents a comprehensive overview, market shares, and growth opportunities of CRISPR And CRISPR-Associated (Cas) Genes market by product type, application, key manufacturers and key regions and countries.

This study specially analyses the impact of Covid-19 outbreak on the CRISPR And CRISPR-Associated (Cas) Genes, covering the supply chain analysis, impact assessment to the CRISPR And CRISPR-Associated (Cas) Genes market size growth rate in several scenarios, and the measures to be undertaken by CRISPR And CRISPR-Associated (Cas) Genes companies in response to the COVID-19 epidemic.

Segmentation by type: breakdown data from 2015 to 2020, in Section 2.3; and forecast to 2025 in section 11.7.

Genome Editing

Genetic engineering

gRNA Database/Gene Librar

CRISPR Plasmid

Human Stem Cells

Genetically Modified Organisms/Crops

Cell Line Engineering

Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2024 in section 11.8.

Biotechnology Companies

Pharmaceutical Companies

Academic Institutes

Research and Development Institutes

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.

Caribou Biosciences

Intellia Therapeutics

Addgene

Merck KGaA

Mirus Bio LLC

CRISPR THERAPEUTICS

Thermo Fisher Scientific

Editas Medicine

Horizon Discovery Group

Takara Bio USA

GE Healthcare Dharmacon

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives

To study and analyze the global CRISPR And CRISPR-Associated (Cas) Genes consumption (value & volume) by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.

To understand the structure of CRISPR And CRISPR-Associated (Cas) Genes market by identifying its various subsegments.

Focuses on the key global CRISPR And CRISPR-Associated (Cas) Genes manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.

To analyze the CRISPR And CRISPR-Associated (Cas) Genes with respect to individual growth trends, future prospects, and their contribution to the total market.

To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).

To project the consumption of CRISPR And CRISPR-Associated (Cas) Genes submarkets, with respect to key regions (along with their respective key countries).

To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

To strategically profile the key players and comprehensively analyze their growth strategies.


Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

1 Scope of the Report

1.1 Market Introduction

1.2 Research Objectives

1.3 Years Considered

1.4 Market Research Methodology

1.5 Data Source

1.6 Economic Indicators

1.7 Currency Considered

1.8 What is the Impact of Covid-19 Outbreak On the CRISPR And CRISPR-Associated (Cas) Genes?

1.8.1 Optimistic Scenario: COVID-19 Is Contained by May or June, with Normalcy Returning to Global Operations Through the End of Q2.

1.8.2 Conservative Scenario: COVID-19 Remains Prevalent, with Continued Impacts Lasting Into Q4.

1.8.3 Estimated Impact of the Coronavirus (COVID-19) Epidemic on the Global CRISPR And CRISPR-Associated (Cas) Genes Market Size in 2020, by Scenario

1.8.4 Corporate Strategy the Manufacturers Should Be Thinking About Right Now

2 Executive Summary

2.1 World Market Overview

2.1.1 Global CRISPR And CRISPR-Associated (Cas) Genes Consumption 2015-2025

2.1.2 CRISPR And CRISPR-Associated (Cas) Genes Consumption CAGR by Region

2.2 CRISPR And CRISPR-Associated (Cas) Genes Segment by Type

2.2.1 Genome Editing

2.2.2 Genetic engineering

2.2.3 gRNA Database/Gene Librar

2.2.4 CRISPR Plasmid

2.2.5 Human Stem Cells

2.2.6 Genetically Modified Organisms/Crops

2.2.7 Cell Line Engineering

2.3 CRISPR And CRISPR-Associated (Cas) Genes Consumption by Type

2.3.1 Global CRISPR And CRISPR-Associated (Cas) Genes Consumption Market Share by Type (2015-2020)

2.3.2 Global CRISPR And CRISPR-Associated (Cas) Genes Revenue and Market Share by Type (2015-2020)

2.3.3 Global CRISPR And CRISPR-Associated (Cas) Genes Sale Price by Type (2015-2020)

2.4 CRISPR And CRISPR-Associated (Cas) Genes Segment by Application

2.4.1 Biotechnology Companies

2.4.2 Pharmaceutical Companies

2.4.3 Academic Institutes

2.4.4 Research and Development Institutes

2.5 CRISPR And CRISPR-Associated (Cas) Genes Consumption by Application

2.5.1 Global CRISPR And CRISPR-Associated (Cas) Genes Consumption Market Share by Type (2015-2020)

2.5.2 Global CRISPR And CRISPR-Associated (Cas) Genes Value and Market Share by Type (2015-2020)

2.5.3 Global CRISPR And CRISPR-Associated (Cas) Genes Sale Price by Type (2015-2020)

3 Global CRISPR And CRISPR-Associated (Cas) Genes by Company

3.1 Global CRISPR And CRISPR-Associated (Cas) Genes Sales Market Share by Company

3.1.1 Global CRISPR And CRISPR-Associated (Cas) Genes Sales by Company (2018-2020)

3.1.2 Global CRISPR And CRISPR-Associated (Cas) Genes Sales Market Share by Company (2018-2020)

3.2 Global CRISPR And CRISPR-Associated (Cas) Genes Revenue Market Share by Company

3.2.1 Global CRISPR And CRISPR-Associated (Cas) Genes Revenue by Company (2018-2020)

3.2.2 Global CRISPR And CRISPR-Associated (Cas) Genes Revenue Market Share by Company (2018-2020)

3.3 Global CRISPR And CRISPR-Associated (Cas) Genes Sale Price by Company

3.4 Global CRISPR And CRISPR-Associated (Cas) Genes Manufacturing Base Distribution, Sales Area, Type by Company

3.4.1 Global CRISPR And CRISPR-Associated (Cas) Genes Manufacturing Base Distribution and Sales Area by Company

3.4.2 Players CRISPR And CRISPR-Associated (Cas) Genes Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 CRISPR And CRISPR-Associated (Cas) Genes by Regions

4.1 CRISPR And CRISPR-Associated (Cas) Genes by Regions

4.2 Americas CRISPR And CRISPR-Associated (Cas) Genes Consumption Growth

4.3 APAC CRISPR And CRISPR-Associated (Cas) Genes Consumption Growth

4.4 Europe CRISPR And CRISPR-Associated (Cas) Genes Consumption Growth

4.5 Middle East & Africa CRISPR And CRISPR-Associated (Cas) Genes Consumption Growth

5 Americas

5.1 Americas CRISPR And CRISPR-Associated (Cas) Genes Consumption by Countries

5.1.1 Americas CRISPR And CRISPR-Associated (Cas) Genes Consumption by Countries (2015-2020)

5.1.2 Americas CRISPR And CRISPR-Associated (Cas) Genes Value by Countries (2015-2020)

5.2 Americas CRISPR And CRISPR-Associated (Cas) Genes Consumption by Type

5.3 Americas CRISPR And CRISPR-Associated (Cas) Genes Consumption by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

5.8 Key Economic Indicators of Few Americas Countries

6 APAC

6.1 APAC CRISPR And CRISPR-Associated (Cas) Genes Consumption by Regions

6.1.1 APAC CRISPR And CRISPR-Associated (Cas) Genes Consumption by Regions (2015-2020)

6.1.2 APAC CRISPR And CRISPR-Associated (Cas) Genes Value by Regions (2015-2020)

6.2 APAC CRISPR And CRISPR-Associated (Cas) Genes Consumption by Type

6.3 APAC CRISPR And CRISPR-Associated (Cas) Genes Consumption by Application

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 Key Economic Indicators of Few APAC Regions

7 Europe

7.1 Europe CRISPR And CRISPR-Associated (Cas) Genes by Countries

7.1.1 Europe CRISPR And CRISPR-Associated (Cas) Genes Consumption by Countries (2015-2020)

7.1.2 Europe CRISPR And CRISPR-Associated (Cas) Genes Value by Countries (2015-2020)

7.2 Europe CRISPR And CRISPR-Associated (Cas) Genes Consumption by Type

7.3 Europe CRISPR And CRISPR-Associated (Cas) Genes Consumption by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

7.9 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa

8.1 Middle East & Africa CRISPR And CRISPR-Associated (Cas) Genes by Countries

8.1.1 Middle East & Africa CRISPR And CRISPR-Associated (Cas) Genes Consumption by Countries (2015-2020)

8.1.2 Middle East & Africa CRISPR And CRISPR-Associated (Cas) Genes Value by Countries (2015-2020)

8.2 Middle East & Africa CRISPR And CRISPR-Associated (Cas) Genes Consumption by Type

8.3 Middle East & Africa CRISPR And CRISPR-Associated (Cas) Genes Consumption by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers and Impact

9.1.1 Growing Demand from Key Regions

9.1.2 Growing Demand from Key Applications and Potential Industries

9.2 Market Challenges and Impact

9.3 Market Trends

10 Marketing, Distributors and Customer

10.1 Sales Channel

10.1.1 Direct Channels

10.1.2 Indirect Channels

10.2 CRISPR And CRISPR-Associated (Cas) Genes Distributors

10.3 CRISPR And CRISPR-Associated (Cas) Genes Customer

11 Global CRISPR And CRISPR-Associated (Cas) Genes Market Forecast

11.1 Global CRISPR And CRISPR-Associated (Cas) Genes Consumption Forecast (2021-2025)

11.2 Global CRISPR And CRISPR-Associated (Cas) Genes Forecast by Regions

11.2.1 Global CRISPR And CRISPR-Associated (Cas) Genes Forecast by Regions (2021-2025)

11.2.2 Global CRISPR And CRISPR-Associated (Cas) Genes Value Forecast by Regions (2021-2025)

11.2.3 Americas Consumption Forecast

11.2.4 APAC Consumption Forecast

11.2.5 Europe Consumption Forecast

11.2.6 Middle East & Africa Consumption Forecast

11.3 Americas Forecast by Countries

11.3.1 United States Market Forecast

11.3.2 Canada Market Forecast

11.3.3 Mexico Market Forecast

11.3.4 Brazil Market Forecast

11.4 APAC Forecast by Countries

11.4.1 China Market Forecast

11.4.2 Japan Market Forecast

11.4.3 Korea Market Forecast

11.4.4 Southeast Asia Market Forecast

11.4.5 India Market Forecast

11.4.6 Australia Market Forecast

11.5 Europe Forecast by Countries

11.5.1 Germany Market Forecast

11.5.2 France Market Forecast

11.5.3 UK Market Forecast

11.5.4 Italy Market Forecast

11.5.5 Russia Market Forecast

11.6 Middle East & Africa Forecast by Countries

11.6.1 Egypt Market Forecast

11.6.2 South Africa Market Forecast

11.6.3 Israel Market Forecast

11.6.4 Turkey Market Forecast

11.6.5 GCC Countries Market Forecast

11.7 Global CRISPR And CRISPR-Associated (Cas) Genes Forecast by Type

11.8 Global CRISPR And CRISPR-Associated (Cas) Genes Forecast by Application

12 Key Players Analysis

12.1 Caribou Biosciences

12.1.1 Company Information

12.1.2 CRISPR And CRISPR-Associated (Cas) Genes Product Offered

12.1.3 Caribou Biosciences CRISPR And CRISPR-Associated (Cas) Genes Sales, Revenue, Price and Gross Margin (2018-2020)

12.1.4 Main Business Overview

12.1.5 Caribou Biosciences Latest Developments

12.2 Intellia Therapeutics

12.2.1 Company Information

12.2.2 CRISPR And CRISPR-Associated (Cas) Genes Product Offered

12.2.3 Intellia Therapeutics CRISPR And CRISPR-Associated (Cas) Genes Sales, Revenue, Price and Gross Margin (2018-2020)

12.2.4 Main Business Overview

12.2.5 Intellia Therapeutics Latest Developments

12.3 Addgene

12.3.1 Company Information

12.3.2 CRISPR And CRISPR-Associated (Cas) Genes Product Offered

12.3.3 Addgene CRISPR And CRISPR-Associated (Cas) Genes Sales, Revenue, Price and Gross Margin (2018-2020)

12.3.4 Main Business Overview

12.3.5 Addgene Latest Developments

12.4 Merck KGaA

12.4.1 Company Information

12.4.2 CRISPR And CRISPR-Associated (Cas) Genes Product Offered

12.4.3 Merck KGaA CRISPR And CRISPR-Associated (Cas) Genes Sales, Revenue, Price and Gross Margin (2018-2020)

12.4.4 Main Business Overview

12.4.5 Merck KGaA Latest Developments

12.5 Mirus Bio LLC

12.5.1 Company Information

12.5.2 CRISPR And CRISPR-Associated (Cas) Genes Product Offered

12.5.3 Mirus Bio LLC CRISPR And CRISPR-Associated (Cas) Genes Sales, Revenue, Price and Gross Margin (2018-2020)

12.5.4 Main Business Overview

12.5.5 Mirus Bio LLC Latest Developments

12.6 CRISPR THERAPEUTICS

12.6.1 Company Information

12.6.2 CRISPR And CRISPR-Associated (Cas) Genes Product Offered

12.6.3 CRISPR THERAPEUTICS CRISPR And CRISPR-Associated (Cas) Genes Sales, Revenue, Price and Gross Margin (2018-2020)

12.6.4 Main Business Overview

12.6.5 CRISPR THERAPEUTICS Latest Developments

12.7 Thermo Fisher Scientific

12.7.1 Company Information

12.7.2 CRISPR And CRISPR-Associated (Cas) Genes Product Offered

12.7.3 Thermo Fisher Scientific CRISPR And CRISPR-Associated (Cas) Genes Sales, Revenue, Price and Gross Margin (2018-2020)

12.7.4 Main Business Overview

12.7.5 Thermo Fisher Scientific Latest Developments

12.8 Editas Medicine

12.8.1 Company Information

12.8.2 CRISPR And CRISPR-Associated (Cas) Genes Product Offered

12.8.3 Editas Medicine CRISPR And CRISPR-Associated (Cas) Genes Sales, Revenue, Price and Gross Margin (2018-2020)

12.8.4 Main Business Overview

12.8.5 Editas Medicine Latest Developments

12.9 Horizon Discovery Group

12.9.1 Company Information

12.9.2 CRISPR And CRISPR-Associated (Cas) Genes Product Offered

12.9.3 Horizon Discovery Group CRISPR And CRISPR-Associated (Cas) Genes Sales, Revenue, Price and Gross Margin (2018-2020)

12.9.4 Main Business Overview

12.9.5 Horizon Discovery Group Latest Developments

12.10 Takara Bio USA

12.10.1 Company Information

12.10.2 CRISPR And CRISPR-Associated (Cas) Genes Product Offered

12.10.3 Takara Bio USA CRISPR And CRISPR-Associated (Cas) Genes Sales, Revenue, Price and Gross Margin (2018-2020)

12.10.4 Main Business Overview

12.10.5 Takara Bio USA Latest Developments

12.11 GE Healthcare Dharmacon

12.11.1 Company Information

12.11.2 CRISPR And CRISPR-Associated (Cas) Genes Product Offered

12.11.3 GE Healthcare Dharmacon CRISPR And CRISPR-Associated (Cas) Genes Sales, Revenue, Price and Gross Margin (2018-2020)

12.11.4 Main Business Overview

12.11.5 GE Healthcare Dharmacon Latest Developments

13 Research Findings and Conclusion

List of Tables

Table 1. Estimated Impact of the Coronavirus (COVID-19) Epidemic on the Global CRISPR And CRISPR-Associated (Cas) Genes Market Size in 2020, by Scenario

Table 2. COVID-19: Measures to be Undertaken by CRISPR And CRISPR-Associated (Cas) Genes Companies

Table 3. Research Methodology

Table 4. Data Source

Table 5. CRISPR And CRISPR-Associated (Cas) Genes Consumption CAGR by Region 2015-2025 ($ Millions)

Table 6. Major Players of Genome Editing

Table 7. Major Players of Genetic engineering

Table 8. Major Players of gRNA Database/Gene Librar

Table 9. Major Players of CRISPR Plasmid

Table 10. Major Players of Human Stem Cells

Table 11. Major Players of Genetically Modified Organisms/Crops

Table 12. Major Players of Cell Line Engineering

Table 13. Global Consumption Sales by Type (2015-2020)

Table 14. Global CRISPR And CRISPR-Associated (Cas) Genes Consumption Market Share by Type (2015-2020)

Table 15. Global CRISPR And CRISPR-Associated (Cas) Genes Revenue by Type (2015-2020) ($ million)

Table 16. Global CRISPR And CRISPR-Associated (Cas) Genes Value Market Share by Type (2015-2020) ($ Millions)

Table 17. Global CRISPR And CRISPR-Associated (Cas) Genes Sale Price by Type (2015-2020)

Table 18. Global Consumption Sales by Application (2015-2020)

Table 19. Global CRISPR And CRISPR-Associated (Cas) Genes Consumption Market Share by Application (2015-2020)

Table 20. Global CRISPR And CRISPR-Associated (Cas) Genes Value by Application (2015-2020)

Table 21. Global CRISPR And CRISPR-Associated (Cas) Genes Value Market Share by Application (2015-2020)

Table 22. Global CRISPR And CRISPR-Associated (Cas) Genes Sale Price by Application (2015-2020)

Table 23. Global CRISPR And CRISPR-Associated (Cas) Genes Sales by Company (2017-2019) (K Units)

Table 24. Global CRISPR And CRISPR-Associated (Cas) Genes Sales Market Share by Company (2017-2019)

Table 25. Global CRISPR And CRISPR-Associated (Cas) Genes Revenue by Company (2017-2019) ($ Millions)

Table 26. Global CRISPR And CRISPR-Associated (Cas) Genes Revenue Market Share by Company (2017-2019)

Table 27. Global CRISPR And CRISPR-Associated (Cas) Genes Sale Price by Company (2017-2019)

Table 28. Global CRISPR And CRISPR-Associated (Cas) Genes Manufacturing Base Distribution and Sales Area by Manufacturers

Table 29. Players CRISPR And CRISPR-Associated (Cas) Genes Products Offered

Table 30. CRISPR And CRISPR-Associated (Cas) Genes Concentration Ratio (CR3, CR5 and CR10) (2017-2019)

Table 31. Global CRISPR And CRISPR-Associated (Cas) Genes Consumption by Regions 2015-2020 (K Units)

Table 32. Global CRISPR And CRISPR-Associated (Cas) Genes Consumption Market Share by Regions 2015-2020

Table 33. Global CRISPR And CRISPR-Associated (Cas) Genes Value by Regions 2015-2020 ($ Millions)

Table 34. Global CRISPR And CRISPR-Associated (Cas) Genes Value Market Share by Regions 2015-2020

Table 35. Americas CRISPR And CRISPR-Associated (Cas) Genes Consumption by Countries (2015-2020) (K Units)

Table 36. Americas CRISPR And CRISPR-Associated (Cas) Genes Consumption Market Share by Countries (2015-2020)

Table 37. Americas CRISPR And CRISPR-Associated (Cas) Genes Value by Countries (2015-2020) ($ Millions)

Table 38. Americas CRISPR And CRISPR-Associated (Cas) Genes Value Market Share by Countries (2015-2020)

Table 39. Americas CRISPR And CRISPR-Associated (Cas) Genes Consumption by Type (2015-2020) (K Units)

Table 40. Americas CRISPR And CRISPR-Associated (Cas) Genes Consumption Market Share by Type (2015-2020)

Table 41. Americas CRISPR And CRISPR-Associated (Cas) Genes Consumption by Application (2015-2020) (K Units)

Table 42. Americas CRISPR And CRISPR-Associated (Cas) Genes Consumption Market Share by Application (2015-2020)

Table 43. APAC CRISPR And CRISPR-Associated (Cas) Genes Consumption by Countries (2015-2020) (K Units)

Table 44. APAC CRISPR And CRISPR-Associated (Cas) Genes Consumption Market Share by Countries (2015-2020)

Table 45. APAC CRISPR And CRISPR-Associated (Cas) Genes Value by Regions (2015-2020) ($ Millions)

Table 46. APAC CRISPR And CRISPR-Associated (Cas) Genes Value Market Share by Regions (2015-2020)

Table 47. APAC CRISPR And CRISPR-Associated (Cas) Genes Consumption by Type (2015-2020) (K Units)

Table 48. APAC CRISPR And CRISPR-Associated (Cas) Genes Consumption Market Share by Type (2015-2020)

Table 49. APAC CRISPR And CRISPR-Associated (Cas) Genes Consumption by Application (2015-2020) (K Units)

Table 50. APAC CRISPR And CRISPR-Associated (Cas) Genes Consumption Market Share by Application (2015-2020)

Table 51. Europe CRISPR And CRISPR-Associated (Cas) Genes Consumption by Countries (2015-2020) (K Units)

Table 52. Europe CRISPR And CRISPR-Associated (Cas) Genes Consumption Market Share by Countries (2015-2020)

Table 53. Europe CRISPR And CRISPR-Associated (Cas) Genes Value by Countries (2015-2020) ($ Millions)

Table 54. Europe CRISPR And CRISPR-Associated (Cas) Genes Value Market Share by Countries (2015-2020)

Table 55. Europe CRISPR And CRISPR-Associated (Cas) Genes Consumption by Type (2015-2020) (K Units)

Table 56. Europe CRISPR And CRISPR-Associated (Cas) Genes Consumption Market Share by Type (2015-2020)

Table 57. Europe CRISPR And CRISPR-Associated (Cas) Genes Consumption by Application (2015-2020) (K Units)

Table 58. Europe CRISPR And CRISPR-Associated (Cas) Genes Consumption Market Share by Application (2015-2020)

Table 59. Middle East & Africa CRISPR And CRISPR-Associated (Cas) Genes Consumption by Countries (2015-2020) (K Units)

Table 60. Middle East & Africa CRISPR And CRISPR-Associated (Cas) Genes Consumption Market Share by Countries (2015-2020)

Table 61. Middle East & Africa CRISPR And CRISPR-Associated (Cas) Genes Value by Countries (2015-2020) ($ Millions)

Table 62. Middle East & Africa CRISPR And CRISPR-Associated (Cas) Genes Value Market Share by Countries (2015-2020)

Table 63. Middle East & Africa CRISPR And CRISPR-Associated (Cas) Genes Consumption by Type (2015-2020) (K Units)

Table 64. Middle East & Africa CRISPR And CRISPR-Associated (Cas) Genes Consumption Market Share by Type (2015-2020)

Table 65. Middle East & Africa CRISPR And CRISPR-Associated (Cas) Genes Consumption by Application (2015-2020) (K Units)

Table 66. Middle East & Africa CRISPR And CRISPR-Associated (Cas) Genes Consumption Market Share by Application (2015-2020)

Table 67. CRISPR And CRISPR-Associated (Cas) Genes Distributors List

Table 68. CRISPR And CRISPR-Associated (Cas) Genes Customer List

Table 69. Global CRISPR And CRISPR-Associated (Cas) Genes Consumption Forecast by Countries (2021-2025) (K Units)

Table 70. Global CRISPR And CRISPR-Associated (Cas) Genes Consumption Market Forecast by Regions

Table 71. Global CRISPR And CRISPR-Associated (Cas) Genes Value Forecast by Countries (2021-2025) ($ Millions)

Table 72. Global CRISPR And CRISPR-Associated (Cas) Genes Value Market Share Forecast by Regions

Table 73. Global CRISPR And CRISPR-Associated (Cas) Genes Consumption Forecast by Type (2021-2025) (K Units)

Table 74. Global CRISPR And CRISPR-Associated (Cas) Genes Consumption Market Share Forecast by Type (2021-2025)

Table 75. Global CRISPR And CRISPR-Associated (Cas) Genes Value Forecast by Type (2021-2025) ($ Millions)

Table 76. Global CRISPR And CRISPR-Associated (Cas) Genes Value Market Share Forecast by Type (2021-2025)

Table 77. Global CRISPR And CRISPR-Associated (Cas) Genes Consumption Forecast by Application (2021-2025) (K Units)

Table 78. Global CRISPR And CRISPR-Associated (Cas) Genes Consumption Market Share Forecast by Application (2021-2025)

Table 79. Global CRISPR And CRISPR-Associated (Cas) Genes Value Forecast by Application (2021-2025) ($ Millions)

Table 80. Global CRISPR And CRISPR-Associated (Cas) Genes Value Market Share Forecast by Application (2021-2025)

Table 81. Caribou Biosciences Product Offered

Table 82. Caribou Biosciences CRISPR And CRISPR-Associated (Cas) Genes Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)

Table 83. Caribou Biosciences Main Business

Table 84. Caribou Biosciences Latest Developments

Table 85. Caribou Biosciences Basic Information, Company Total Revenue (in $ million), CRISPR And CRISPR-Associated (Cas) Genes Manufacturing Base, Sales Area and Its Competitors

Table 86. Intellia Therapeutics Product Offered

Table 87. Intellia Therapeutics CRISPR And CRISPR-Associated (Cas) Genes Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)

Table 88. Intellia Therapeutics Main Business

Table 89. Intellia Therapeutics Latest Developments

Table 90. Intellia Therapeutics Basic Information, Company Total Revenue (in $ million), CRISPR And CRISPR-Associated (Cas) Genes Manufacturing Base, Sales Area and Its Competitors

Table 91. Addgene Product Offered

Table 92. Addgene CRISPR And CRISPR-Associated (Cas) Genes Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)

Table 93. Addgene Main Business

Table 94. Addgene Latest Developments

Table 95. Addgene Basic Information, Company Total Revenue (in $ million), CRISPR And CRISPR-Associated (Cas) Genes Manufacturing Base, Sales Area and Its Competitors

Table 96. Merck KGaA Product Offered

Table 97. Merck KGaA CRISPR And CRISPR-Associated (Cas) Genes Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)

Table 98. Merck KGaA Main Business

Table 99. Merck KGaA Latest Developments

Table 100. Merck KGaA Basic Information, Company Total Revenue (in $ million), CRISPR And CRISPR-Associated (Cas) Genes Manufacturing Base, Sales Area and Its Competitors

Table 101. Mirus Bio LLC Product Offered

Table 102. Mirus Bio LLC CRISPR And CRISPR-Associated (Cas) Genes Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)

Table 103. Mirus Bio LLC Main Business

Table 104. Mirus Bio LLC Latest Developments

Table 105. Mirus Bio LLC Basic Information, Company Total Revenue (in $ million), CRISPR And CRISPR-Associated (Cas) Genes Manufacturing Base, Sales Area and Its Competitors

Table 106. CRISPR THERAPEUTICS Product Offered

Table 107. CRISPR THERAPEUTICS CRISPR And CRISPR-Associated (Cas) Genes Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)

Table 108. CRISPR THERAPEUTICS Main Business

Table 109. CRISPR THERAPEUTICS Latest Developments

Table 110. CRISPR THERAPEUTICS Basic Information, Company Total Revenue (in $ million), CRISPR And CRISPR-Associated (Cas) Genes Manufacturing Base, Sales Area and Its Competitors

Table 111. Thermo Fisher Scientific Product Offered

Table 112. Thermo Fisher Scientific Basic Information, Company Total Revenue (in $ million), CRISPR And CRISPR-Associated (Cas) Genes Manufacturing Base, Sales Area and Its Competitors

Table 113. Thermo Fisher Scientific Main Business

Table 114. Thermo Fisher Scientific Latest Developments

Table 115. Thermo Fisher Scientific CRISPR And CRISPR-Associated (Cas) Genes Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)

Table 116. Editas Medicine Product Offered

Table 117. Editas Medicine CRISPR And CRISPR-Associated (Cas) Genes Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)

Table 118. Editas Medicine Main Business

Table 119. Editas Medicine Latest Developments

Table 120. Editas Medicine Basic Information, Company Total Revenue (in $ million), CRISPR And CRISPR-Associated (Cas) Genes Manufacturing Base, Sales Area and Its Competitors

Table 121. Horizon Discovery Group Product Offered

Table 122. Horizon Discovery Group CRISPR And CRISPR-Associated (Cas) Genes Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)

Table 123. Horizon Discovery Group Main Business

Table 124. Horizon Discovery Group Latest Developments

Table 125. Horizon Discovery Group Basic Information, Company Total Revenue (in $ million), CRISPR And CRISPR-Associated (Cas) Genes Manufacturing Base, Sales Area and Its Competitors

Table 126. Takara Bio USA Product Offered

Table 127. Takara Bio USA CRISPR And CRISPR-Associated (Cas) Genes Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)

Table 128. Takara Bio USA Main Business

Table 129. Takara Bio USA Latest Developments

Table 130. Takara Bio USA Basic Information, Company Total Revenue (in $ million), CRISPR And CRISPR-Associated (Cas) Genes Manufacturing Base, Sales Area and Its Competitors

Table 131. GE Healthcare Dharmacon Product Offered

Table 132. GE Healthcare Dharmacon CRISPR And CRISPR-Associated (Cas) Genes Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)

Table 133. GE Healthcare Dharmacon Main Business

Table 134. GE Healthcare Dharmacon Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table 135. GE Healthcare Dharmacon Latest Developments

List of Figures

Figure 1. Picture of CRISPR And CRISPR-Associated (Cas) Genes

Figure 2. CRISPR And CRISPR-Associated (Cas) Genes Report Years Considered

Figure 3. Market Research Methodology

Figure 4. Global CRISPR And CRISPR-Associated (Cas) Genes Consumption Growth Rate 2015-2025 (K Units)

Figure 5. Global CRISPR And CRISPR-Associated (Cas) Genes Value Growth Rate 2015-2025 ($ Millions)

Figure 6. Product Picture of Genome Editing

Figure 7. Product Picture of Genetic engineering

Figure 8. Product Picture of gRNA Database/Gene Librar

Figure 9. Product Picture of CRISPR Plasmid

Figure 10. Product Picture of Human Stem Cells

Figure 11. Product Picture of Genetically Modified Organisms/Crops

Figure 12. Product Picture of Cell Line Engineering

Figure 13. Global CRISPR And CRISPR-Associated (Cas) Genes Consumption Market Share by Type (2015-2020)

Figure 14. Global CRISPR And CRISPR-Associated (Cas) Genes Value Market Share by Type (2015-2020)

Figure 15. CRISPR And CRISPR-Associated (Cas) Genes Consumed in Biotechnology Companies

Figure 16. Global CRISPR And CRISPR-Associated (Cas) Genes Market: Biotechnology Companies (2015-2020) (K Units)

Figure 17. Global CRISPR And CRISPR-Associated (Cas) Genes Market: Biotechnology Companies (2015-2020) ($ Millions)

Figure 18. CRISPR And CRISPR-Associated (Cas) Genes Consumed in Pharmaceutical Companies

Figure 19. Global CRISPR And CRISPR-Associated (Cas) Genes Market: Pharmaceutical Companies (2015-2020) (K Units)

Figure 20. Global CRISPR And CRISPR-Associated (Cas) Genes Market: Pharmaceutical Companies (2015-2020) ($ Millions)

Figure 21. CRISPR And CRISPR-Associated (Cas) Genes Consumed in Academic Institutes

Figure 22. Global CRISPR And CRISPR-Associated (Cas) Genes Market: Academic Institutes (2015-2020) (K Units)

Figure 23. Global CRISPR And CRISPR-Associated (Cas) Genes Market: Academic Institutes (2015-2020) ($ Millions)

Figure 24. CRISPR And CRISPR-Associated (Cas) Genes Consumed in Research and Development Institutes

Figure 25. Global CRISPR And CRISPR-Associated (Cas) Genes Market: Research and Development Institutes (2015-2020) (K Units)

Figure 26. Global CRISPR And CRISPR-Associated (Cas) Genes Market: Research and Development Institutes (2015-2020) ($ Millions)

Figure 27. Global CRISPR And CRISPR-Associated (Cas) Genes Consumption Market Share by Application (2015-2020)

Figure 28. Global CRISPR And CRISPR-Associated (Cas) Genes Value Market Share by Application (2015-2020)

Figure 29. Global CRISPR And CRISPR-Associated (Cas) Genes Sales Market Share by Company in 2017

Figure 30. Global CRISPR And CRISPR-Associated (Cas) Genes Sales Market Share by Company in 2019

Figure 31. Global CRISPR And CRISPR-Associated (Cas) Genes Revenue Market Share by Company in 2017

Figure 32. Global CRISPR And CRISPR-Associated (Cas) Genes Revenue Market Share by Company in 2019

Figure 33. Global CRISPR And CRISPR-Associated (Cas) Genes Sale Price by Company in 2019

Figure 34. Global CRISPR And CRISPR-Associated (Cas) Genes Consumption Market Share by Regions 2015-2020

Figure 35. Global CRISPR And CRISPR-Associated (Cas) Genes Value Market Share by Regions 2015-2020

Figure 36. Americas CRISPR And CRISPR-Associated (Cas) Genes Consumption 2015-2020 (K Units)

Figure 37. Americas CRISPR And CRISPR-Associated (Cas) Genes Value 2015-2020 ($ Millions)

Figure 38. APAC CRISPR And CRISPR-Associated (Cas) Genes Consumption 2015-2020 (K Units)

Figure 39. APAC CRISPR And CRISPR-Associated (Cas) Genes Value 2015-2020 ($ Millions)

Figure 40. Europe CRISPR And CRISPR-Associated (Cas) Genes Consumption 2015-2020 (K Units)

Figure 41. Europe CRISPR And CRISPR-Associated (Cas) Genes Value 2015-2020 ($ Millions)

Figure 42. Middle East & Africa CRISPR And CRISPR-Associated (Cas) Genes Consumption 2015-2020 (K Units)

Figure 43. Middle East & Africa CRISPR And CRISPR-Associated (Cas) Genes Value 2015-2020 ($ Millions)

Figure 44. Americas CRISPR And CRISPR-Associated (Cas) Genes Consumption Market Share by Countries in 2019

Figure 45. Americas CRISPR And CRISPR-Associated (Cas) Genes Value Market Share by Countries in 2019

Figure 46. Americas CRISPR And CRISPR-Associated (Cas) Genes Consumption Market Share by Type in 2019

Figure 47. Americas CRISPR And CRISPR-Associated (Cas) Genes Consumption Market Share by Application in 2019

Figure 48. United States CRISPR And CRISPR-Associated (Cas) Genes Consumption Growth 2015-2020 (K Units)

Figure 49. United States CRISPR And CRISPR-Associated (Cas) Genes Value Growth 2015-2020 ($ Millions)

Figure 50. Canada CRISPR And CRISPR-Associated (Cas) Genes Consumption Growth 2015-2020 (K Units)

Figure 51. Canada CRISPR And CRISPR-Associated (Cas) Genes Value Growth 2015-2020 ($ Millions)

Figure 52. Mexico CRISPR And CRISPR-Associated (Cas) Genes Consumption Growth 2015-2020 (K Units)

Figure 53. Mexico CRISPR And CRISPR-Associated (Cas) Genes Value Growth 2015-2020 ($ Millions)

Figure 54. APAC CRISPR And CRISPR-Associated (Cas) Genes Consumption Market Share by Countries in 2019

Figure 55. APAC CRISPR And CRISPR-Associated (Cas) Genes Value Market Share by Regions in 2019

Figure 56. APAC CRISPR And CRISPR-Associated (Cas) Genes Consumption Market Share by Type in 2019

Figure 57. APAC CRISPR And CRISPR-Associated (Cas) Genes Consumption Market Share by Application in 2019

Figure 58. China CRISPR And CRISPR-Associated (Cas) Genes Consumption Growth 2015-2020 (K Units)

Figure 59. China CRISPR And CRISPR-Associated (Cas) Genes Value Growth 2015-2020 ($ Millions)

Figure 60. Japan CRISPR And CRISPR-Associated (Cas) Genes Consumption Growth 2015-2020 (K Units)

Figure 61. Japan CRISPR And CRISPR-Associated (Cas) Genes Value Growth 2015-2020 ($ Millions)

Figure 62. Korea CRISPR And CRISPR-Associated (Cas) Genes Consumption Growth 2015-2020 (K Units)

Figure 63. Korea CRISPR And CRISPR-Associated (Cas) Genes Value Growth 2015-2020 ($ Millions)

Figure 64. Southeast Asia CRISPR And CRISPR-Associated (Cas) Genes Consumption Growth 2015-2020 (K Units)

Figure 65. Southeast Asia CRISPR And CRISPR-Associated (Cas) Genes Value Growth 2015-2020 ($ Millions)

Figure 66. India CRISPR And CRISPR-Associated (Cas) Genes Consumption Growth 2015-2020 (K Units)

Figure 67. India CRISPR And CRISPR-Associated (Cas) Genes Value Growth 2015-2020 ($ Millions)

Figure 68. Australia CRISPR And CRISPR-Associated (Cas) Genes Consumption Growth 2015-2020 (K Units)

Figure 69. Australia CRISPR And CRISPR-Associated (Cas) Genes Value Growth 2015-2020 ($ Millions)

Figure 70. Europe CRISPR And CRISPR-Associated (Cas) Genes Consumption Market Share by Countries in 2019

Figure 71. Europe CRISPR And CRISPR-Associated (Cas) Genes Value Market Share by Countries in 2019

Figure 72. Europe CRISPR And CRISPR-Associated (Cas) Genes Consumption Market Share by Type in 2019

Figure 73. Europe CRISPR And CRISPR-Associated (Cas) Genes Consumption Market Share by Application in 2019

Figure 74. Germany CRISPR And CRISPR-Associated (Cas) Genes Consumption Growth 2015-2020 (K Units)

Figure 75. Germany CRISPR And CRISPR-Associated (Cas) Genes Value Growth 2015-2020 ($ Millions)

Figure 76. France CRISPR And CRISPR-Associated (Cas) Genes Consumption Growth 2015-2020 (K Units)

Figure 77. France CRISPR And CRISPR-Associated (Cas) Genes Value Growth 2015-2020 ($ Millions)

Figure 78. UK CRISPR And CRISPR-Associated (Cas) Genes Consumption Growth 2015-2020 (K Units)

Figure 79. UK CRISPR And CRISPR-Associated (Cas) Genes Value Growth 2015-2020 ($ Millions)

Figure 80. Italy CRISPR And CRISPR-Associated (Cas) Genes Consumption Growth 2015-2020 (K Units)

Figure 81. Italy CRISPR And CRISPR-Associated (Cas) Genes Value Growth 2015-2020 ($ Millions)

Figure 82. Russia CRISPR And CRISPR-Associated (Cas) Genes Consumption Growth 2015-2020 (K Units)

Figure 83. Russia CRISPR And CRISPR-Associated (Cas) Genes Value Growth 2015-2020 ($ Millions)

Figure 84. Middle East & Africa CRISPR And CRISPR-Associated (Cas) Genes Consumption Market Share by Countries in 2019

Figure 85. Middle East & Africa CRISPR And CRISPR-Associated (Cas) Genes Value Market Share by Countries in 2019

Figure 86. Middle East & Africa CRISPR And CRISPR-Associated (Cas) Genes Consumption Market Share by Type in 2019

Figure 87. Middle East & Africa CRISPR And CRISPR-Associated (Cas) Genes Consumption Market Share by Application in 2019

Figure 88. Egypt CRISPR And CRISPR-Associated (Cas) Genes Consumption Growth 2015-2020 (K Units)

Figure 89. Egypt CRISPR And CRISPR-Associated (Cas) Genes Value Growth 2015-2020 ($ Millions)

Figure 90. South Africa CRISPR And CRISPR-Associated (Cas) Genes Consumption Growth 2015-2020 (K Units)

Figure 91. South Africa CRISPR And CRISPR-Associated (Cas) Genes Value Growth 2015-2020 ($ Millions)

Figure 92. Israel CRISPR And CRISPR-Associated (Cas) Genes Consumption Growth 2015-2020 (K Units)

Figure 93. Israel CRISPR And CRISPR-Associated (Cas) Genes Value Growth 2015-2020 ($ Millions)

Figure 94. Turkey CRISPR And CRISPR-Associated (Cas) Genes Consumption Growth 2015-2020 (K Units)

Figure 95. Turkey CRISPR And CRISPR-Associated (Cas) Genes Value Growth 2015-2020 ($ Millions)

Figure 96. GCC Countries CRISPR And CRISPR-Associated (Cas) Genes Consumption Growth 2015-2020 (K Units)

Figure 97. GCC Countries CRISPR And CRISPR-Associated (Cas) Genes Value Growth 2015-2020 ($ Millions)

Figure 98. Global CRISPR And CRISPR-Associated (Cas) Genes Consumption Growth Rate Forecast (2021-2025) (K Units)

Figure 99. Global CRISPR And CRISPR-Associated (Cas) Genes Value Growth Rate Forecast (2021-2025) ($ Millions)

Figure 100. Americas CRISPR And CRISPR-Associated (Cas) Genes Consumption 2021-2025 (K Units)

Figure 101. Americas CRISPR And CRISPR-Associated (Cas) Genes Value 2021-2025 ($ Millions)

Figure 102. APAC CRISPR And CRISPR-Associated (Cas) Genes Consumption 2021-2025 (K Units)

Figure 103. APAC CRISPR And CRISPR-Associated (Cas) Genes Value 2021-2025 ($ Millions)

Figure 104. Europe CRISPR And CRISPR-Associated (Cas) Genes Consumption 2021-2025 (K Units)

Figure 105. Europe CRISPR And CRISPR-Associated (Cas) Genes Value 2021-2025 ($ Millions)

Figure 106. Middle East & Africa CRISPR And CRISPR-Associated (Cas) Genes Consumption 2021-2025 (K Units)

Figure 107. Middle East & Africa CRISPR And CRISPR-Associated (Cas) Genes Value 2021-2025 ($ Millions)

Figure 108. United States CRISPR And CRISPR-Associated (Cas) Genes Consumption 2021-2025 (K Units)

Figure 109. United States CRISPR And CRISPR-Associated (Cas) Genes Value 2021-2025 ($ Millions)

Figure 110. Canada CRISPR And CRISPR-Associated (Cas) Genes Consumption 2021-2025 (K Units)

Figure 111. Canada CRISPR And CRISPR-Associated (Cas) Genes Value 2021-2025 ($ Millions)

Figure 112. Mexico CRISPR And CRISPR-Associated (Cas) Genes Consumption 2021-2025 (K Units)

Figure 113. Mexico CRISPR And CRISPR-Associated (Cas) Genes Value 2021-2025 ($ Millions)

Figure 114. Brazil CRISPR And CRISPR-Associated (Cas) Genes Consumption 2021-2025 (K Units)

Figure 115. Brazil CRISPR And CRISPR-Associated (Cas) Genes Value 2021-2025 ($ Millions)

Figure 116. China CRISPR And CRISPR-Associated (Cas) Genes Consumption 2021-2025 (K Units)

Figure 117. China CRISPR And CRISPR-Associated (Cas) Genes Value 2021-2025 ($ Millions)

Figure 118. Japan CRISPR And CRISPR-Associated (Cas) Genes Consumption 2021-2025 (K Units)

Figure 119. Japan CRISPR And CRISPR-Associated (Cas) Genes Value 2021-2025 ($ Millions)

Figure 120. Korea CRISPR And CRISPR-Associated (Cas) Genes Consumption 2021-2025 (K Units)

Figure 121. Korea CRISPR And CRISPR-Associated (Cas) Genes Value 2021-2025 ($ Millions)

Figure 122. Southeast Asia CRISPR And CRISPR-Associated (Cas) Genes Consumption 2021-2025 (K Units)

Figure 123. Southeast Asia CRISPR And CRISPR-Associated (Cas) Genes Value 2021-2025 ($ Millions)

Figure 124. India CRISPR And CRISPR-Associated (Cas) Genes Consumption 2021-2025 (K Units)

Figure 125. India CRISPR And CRISPR-Associated (Cas) Genes Value 2021-2025 ($ Millions)

Figure 126. Australia CRISPR And CRISPR-Associated (Cas) Genes Consumption 2021-2025 (K Units)

Figure 127. Australia CRISPR And CRISPR-Associated (Cas) Genes Value 2021-2025 ($ Millions)

Figure 128. Germany CRISPR And CRISPR-Associated (Cas) Genes Consumption 2021-2025 (K Units)

Figure 129. Germany CRISPR And CRISPR-Associated (Cas) Genes Value 2021-2025 ($ Millions)

Figure 130. France CRISPR And CRISPR-Associated (Cas) Genes Consumption 2021-2025 (K Units)

Figure 131. France CRISPR And CRISPR-Associated (Cas) Genes Value 2021-2025 ($ Millions)

Figure 132. UK CRISPR And CRISPR-Associated (Cas) Genes Consumption 2021-2025 (K Units)

Figure 133. UK CRISPR And CRISPR-Associated (Cas) Genes Value 2021-2025 ($ Millions)

Figure 134. Italy CRISPR And CRISPR-Associated (Cas) Genes Consumption 2021-2025 (K Units)

Figure 135. Italy CRISPR And CRISPR-Associated (Cas) Genes Value 2021-2025 ($ Millions)

Figure 136. Russia CRISPR And CRISPR-Associated (Cas) Genes Consumption 2021-2025 (K Units)

Figure 137. Russia CRISPR And CRISPR-Associated (Cas) Genes Value 2021-2025 ($ Millions)

Figure 138. Spain CRISPR And CRISPR-Associated (Cas) Genes Consumption 2021-2025 (K Units)

Figure 139. Spain CRISPR And CRISPR-Associated (Cas) Genes Value 2021-2025 ($ Millions)

Figure 140. Egypt CRISPR And CRISPR-Associated (Cas) Genes Consumption 2021-2025 (K Units)

Figure 141. Egypt CRISPR And CRISPR-Associated (Cas) Genes Value 2021-2025 ($ Millions)

Figure 142. South Africa CRISPR And CRISPR-Associated (Cas) Genes Consumption 2021-2025 (K Units)

Figure 143. South Africa CRISPR And CRISPR-Associated (Cas) Genes Value 2021-2025 ($ Millions)

Figure 144. Israel CRISPR And CRISPR-Associated (Cas) Genes Consumption 2021-2025 (K Units)

Figure 145. Israel CRISPR And CRISPR-Associated (Cas) Genes Value 2021-2025 ($ Millions)

Figure 146. Turkey CRISPR And CRISPR-Associated (Cas) Genes Consumption 2021-2025 (K Units)

Figure 147. Turkey CRISPR And CRISPR-Associated (Cas) Genes Value 2021-2025 ($ Millions)

Figure 148. GCC Countries CRISPR And CRISPR-Associated (Cas) Genes Consumption 2021-2025 (K Units)

Figure 149. GCC Countries CRISPR And CRISPR-Associated (Cas) Genes Value 2021-2025 ($ Millions)

Figure 150. Caribou Biosciences CRISPR And CRISPR-Associated (Cas) Genes Market Share (2018-2020)

Figure 151. Intellia Therapeutics CRISPR And CRISPR-Associated (Cas) Genes Market Share (2018-2020)

Figure 152. Addgene CRISPR And CRISPR-Associated (Cas) Genes Market Share (2018-2020)

Figure 153. Merck KGaA CRISPR And CRISPR-Associated (Cas) Genes Market Share (2018-2020)

Figure 154. Mirus Bio LLC CRISPR And CRISPR-Associated (Cas) Genes Market Share (2018-2020)

Figure 155. CRISPR THERAPEUTICS CRISPR And CRISPR-Associated (Cas) Genes Market Share (2018-2020)

Figure 156. Thermo Fisher Scientific CRISPR And CRISPR-Associated (Cas) Genes Market Share (2018-2020)

Figure 157. Editas Medicine CRISPR And CRISPR-Associated (Cas) Genes Market Share (2018-2020)

Figure 158. Horizon Discovery Group CRISPR And CRISPR-Associated (Cas) Genes Market Share (2018-2020)

Figure 159. Takara Bio USA CRISPR And CRISPR-Associated (Cas) Genes Market Share (2018-2020)

Figure 160. GE Healthcare Dharmacon CRISPR And CRISPR-Associated (Cas) Genes Market Share (2018-2020)

Sample Request is not available